|
1
|
Warshauer JT, Bluestone JA and Anderson
MS: New frontiers in the treatment of type 1 diabetes. Cell Metab.
31:46–61. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Guemes M, Rahman SA and Hussain K: What is
a normal blood glucose? Arch Dis Child. 101:569–574.
2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Han HS, Kang G, Kim JS, Choi BH and Koo
SH: Regulation of glucose metabolism from a liver-centric
perspective. Exp Mol Med. 48(e218)2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Petersen MC, Vatner DF and Shulman GI:
Regulation of hepatic glucose metabolism in health and disease. Nat
Rev Endocrinol. 13:572–587. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hu Z, Li E, Sullivan MA, Tan X, Deng B,
Gilbert RG and Li C: Glycogen structure in type 1 diabetic mice:
Towards understanding the origin of diabetic glycogen molecular
fragility. Int J Biol Macromol. 128:665–672. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Marinkovic T and Oresic M: Modeling
strategies to study metabolic pathways in progression to type 1
diabetes-Challenges and opportunities. Arch Biochem Biophys.
589:131–137. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Morio B, Panthu B, Bassot A and Rieusset
J: Role of mitochondria in liver metabolic health and diseases.
Cell Calcium. 94(102336)2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Franko A, von Kleist-Retzow JC, Neschen S,
Wu M, Schommers P, Böse M, Kunze A, Hartmann U, Sanchez-Lasheras C,
Stoehr O, et al: Liver adapts mitochondrial function to insulin
resistant and diabetic states in mice. J Hepatol. 60:816–823.
2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wang Y, Han P, Wang M, Weng W, Zhan H, Yu
X, Yuan C, Shao M and Sun H: Artemether improves type 1 diabetic
kidney disease by regulating mitochondrial function. Am J Transl
Res. 11:3879–3889. 2019.PubMed/NCBI
|
|
10
|
Han P, Wang Y, Zhan H, Weng W, Yu X, Ge N,
Wang W, Song G, Yi T, Li S, et al: Artemether ameliorates type 2
diabetic kidney disease by increasing mitochondrial pyruvate
carrier content in db/db mice. Am J Transl Res. 11:1389–1402.
2019.PubMed/NCBI
|
|
11
|
Han P, Zhan H, Shao M, Wang W, Song G, Yu
X, Zhang C, Ge N, Yi T, Li S and Sun H: Niclosamide ethanolamine
improves kidney injury in db/db mice. Diabetes Res Clin Pract.
144:25–33. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Han P, Shao M, Guo L, Wang W, Song G, Yu
X, Zhang C, Ge N, Yi T, Li S, et al: Niclosamide ethanolamine
improves diabetes and diabetic kidney disease in mice. Am J Transl
Res. 10:1071–1084. 2018.PubMed/NCBI
|
|
13
|
Chen W, Mook RA Jr, Premont RT and Wang J:
Niclosamide: Beyond an antihelminthic drug. Cell Signal. 41:89–96.
2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Tsui KH, Wu MY, Lin LT, Wen ZH, Li YH, Chu
PY and Li CJ: Disruption of mitochondrial homeostasis with
artemisinin unravels anti-angiogenesis effects via auto-paracrine
mechanisms. Theranostics. 9:6631–6645. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Carroll NV, Longley RW and Roe JH: The
determination of glycogen in liver and muscle by use of anthrone
reagent. J Biol Chem. 220:583–593. 1956.PubMed/NCBI
|
|
16
|
Wang Y, Wang Y, You F and Xue J: Novel use
for old drugs: The emerging role of artemisinin and its derivatives
in fibrosis. Pharmacol Res. 157(104829)2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Park JS, Lee YS, Lee DH and Bae SH:
Repositioning of niclosamide ethanolamine (NEN), an anthelmintic
drug, for the treatment of lipotoxicity. Free Radic Biol Med.
137:143–157. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lopez-Soldado I, Guinovart JJ and Duran J:
Increasing hepatic glycogen moderates the diabetic phenotype in
insulin-deficient Akita mice. J Biol Chem.
296(100498)2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Hwang JH, Perseghin G, Rothman DL, Cline
GW, Magnusson I, Petersen KF and Shulman GI: Impaired net hepatic
glycogen synthesis in insulin-dependent diabetic subjects during
mixed meal ingestion. A 13C nuclear magnetic resonance spectroscopy
study. J Clin Invest. 95:783–787. 1995.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Hutton JC and O'Brien RM:
Glucose-6-phosphatase catalytic subunit gene family. J Biol Chem.
284:29241–29245. 2009.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Lizak B, Szarka A, Kim Y, Choi KS, Németh
CE, Marcolongo P, Benedetti A, Bánhegyi G and Margittai É: Glucose
transport and transporters in the endomembranes. Int J Mol Sci.
20(5898)2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Chipuk JE, Mohammed JN, Gelles JD and Chen
Y: Mechanistic connections between mitochondrial biology and
regulated cell death. Dev Cell. 56:1221–1233. 2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Pfanner N, Warscheid B and Wiedemann N:
Mitochondrial proteins: From biogenesis to functional networks. Nat
Rev Mol Cell Biol. 20:267–284. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yu S, Meng S, Xiang M and Ma H:
Phosphoenolpyruvate carboxykinase in cell metabolism: Roles and
mechanisms beyond gluconeogenesis. Mol Metab.
53(101257)2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
White PJ, McGarrah RW, Grimsrud PA, Tso
SC, Yang WH, Haldeman JM, Grenier-Larouche T, An J, Lapworth AL,
Astapova I, et al: The BCKDH kinase and phosphatase integrate BCAA
and lipid metabolism via regulation of ATP-Citrate lyase. Cell
Metab. 27:1281–1293.e7. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lynch CJ and Adams SH: Branched-chain
amino acids in metabolic signalling and insulin resistance. Nat Rev
Endocrinol. 10:723–736. 2014.PubMed/NCBI View Article : Google Scholar
|
